BNET Industries

Pharmion Corp.

(PHRM) is in the Pharma Industry

Last Fiscal Year Sales:$221.2M
  • Public
  • US
Dow Jones Description

Celgene was initially founded as a unit of the Celanese Corporation in 1980. However, following the 1986 merger of Celanese Corporation with American Hoechst Corporation, Celgene was spun off as an independent biopharmaceutical company. In July 1998, the company received approval from the FDA to market THALOMID (thalidomide) for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence. In May 2006, Celgene received approval for THALOMID in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myeloma. In April 2000, an agreement was reached with Novartis Pharma AG to license d-MPH our chirally pure version of RITALIN CII. The FDA subsequently granted approval to market d-MPH or FOCALIN XR CII in November 2001. On August 31, 2000, with products on the market, Celgene completed a merger with Signal Pharmaceuticals, Inc., a privately held biopharmaceutical company focusing on the discovery and development of drugs that regulate genes associated with disease. ...

Chairman and Chief Executive Officer
Sol J. Barer PhD
Number of Employees 328
Contact Information

2525 28th St Ste 200

Boulder, Colorado 80301

pharmion.com

(720) 564-9100

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

pharmion corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Robert J. Hugin President and Chief Operating Officer
Andrew Allen Chief Medical Officer
David W. Gryska Senior Vice President & Chief Financial Officer
Michael Cosgrave Chief Commercial Officer
Gillian C. Ivers-Read Executive Vice President
Barrie L. Alioth Vice President, Strategic Planning
Jay Backstrom Vice President, Global Medical & Safety
Jeff Knapp Vice President, Sales, Marketing
Jeffrey L. Davis Vice President, Information Technology
Jeffrey P. Davis Vice President, Information Technology
Steven DuPont Vice President and General Counsel
Anna Sussman Director, Corp Communications
Breanna Burkart Director, Investor Relations
John Byrd Director, Conferences
Andrea Bacigalupo
Norbert Schmitz
Edward J. McKinley Director
John C. Reed Director
Judith A. Hemberger Co-Founder
Dayton Misfeldt Investor
Michael D. Casey Committee Member
Thorlef Spickschen Member

Board of Directors

Name (plus bio) Position
Sol J. Barer PhD Chairman and Chief Executive Officer
Arthur Hull Hayes Jr Board of Directors
Brian G. Atwood Board Member
Brian GAtwood Board Member
Ernest Mario PhD Board of Directors
Gilla Kaplan Board of Directors
James Barrett Board of Directors
James C. Blair Board of Directors
James Loughlin Board of Directors
M. James Barrett Board Member
Rodman L. Drake Board of Directors
Thorlef Spickchen Board of Directors
Walter L Robb Board of Directors

Organization Position Status
Rare Diseases Clinical Research Network Chairman and Chief Executive Officer Current
Pharmion Corporation Chairman and Chief Executive Officer Current
Lead Discovery Chairman and Chief Executive Officer Current
Celgene Corporation Chairman of the Board Current
Semorex Inc. Director Current
Biotechnology Council of New Jersey, Inc Board of Directors Current
Global Capital Associates Board of Directors Current
Multiple Myeloma Chairman and Chief Executive Officer Former
Celgene Corporation Chief Executive Officer Former
Rare Diseases Clinical Research Network President Former
Celgene Corporation COO Former
Rutgers University Ph.D. In Organic and Former

Robert J. Hugin has been a director since April 2003. Since May 2006, Mr. Hugin has served as the President and Chief Operating Officer of Celgene Corporation, a biopharmaceutical company focused on cancer and immunological diseases. From June 1999 to May 2006, Mr. Hugin served as the Senior Vice President and Chief Financial Officer of Celgene. From 1985 to 1999, Mr. Hugin held positions with J.P. Morgan & Co. Inc., an investment banking firm, serving most recently as a Managing Director. Mr. Hugin is a director of Celgene Corporation and Atlantic Health System, Inc. Mr. Hugin received an A.B. from Princeton University and an M.B.A. from the University of Virginia.

Organization Position Status
Celgene Corporation President Current
Lead Discovery President and Chief Operating Officer Current
Rare Diseases Clinical Research Network President and Chief Operating Officer Current
Pharmion Corporation President and Chief Operating Officer Current
Celgene Corporation Chief Operating Officer Current
The Medicines Company Independent Director, Chair of Audit Committee Current
Angiox Independent Director, Chair of Audit Committee Current
Cancer Immunity Board of Directors Current
Family Promise Board of Directors Current
Atlantic Health System Inc. Director Current
Celgene Corporation Board of Directors Current
Coley Pharmaceutical Group Inc. Director Current
Rare Diseases Clinical Research Network Senior Vice President and Chief Financial Officer Former
Multiple Myeloma Senior Vice President and Chief Financial Officer Former
Celgene Corporation Senior Vice President Former
United States, Inc. Marine Corps Infantry Officer Former
University of Virginia M.B.A. Former
Princeton University A.B. Former

Organization Position Status
Pharmion Corporation Chief Medical Officer Current

Organization Position Status
Multiple Myeloma Senior Vice President & Chief Financial Officer Current
Pharmion Corporation Senior Vice President & Chief Financial Officer Current
Celgene Corporation Chief Financial Officer Current
Rare Diseases Clinical Research Network Senior Vice President & Chief Financial Officer Current
Seattle Genetics, Inc. Board of Directors Current
CoTherix, Inc. Board of Directors Current
Seattle Genetics, Inc. CEO, Biotechnology Former
Scios, Inc. Chief Financial Officer Former
Scios, Inc. Senior Vice President Former
Young Corporation Partner Former
Ernst & Young partner Former
Strategic Consulting Group Principal Former
Golden Gate University M.B.A. Former
Golden Gate University B.A. In Accounting Former
Loyola University B.A. In Accounting Former
Seattle Genetics, Inc. member Former
CoTherix, Inc. member Former

Organization Position Status
Pharmion Corporation Chief Commercial Officer Current
Pharmion Corporation Executive Vice President, Global Commercial Operations Former

Organization Position Status
Montagu Newhall Associates, Inc. Executive Vice President, Development Operations Current
Rivervest Venture Management, LLC Executive Vice President, Development Operations Current
The Mds Foundation Executive Vice President Current
Bio-Path Holdings, Inc. Executive Vice President, Development Operations Current
Pharmion Corporation Executive Vice President Current
Marion Merrell Dow Regulatory Affairs Director Former
Aventis Pharmaceuticals Inc Former
Marion Merrell Dow Director Former

Organization Position Status
Marrowforums Vice President, Strategic Planning Current
Montagu Newhall Associates, Inc. Vice President, Strategic Planning Current
The Mds Foundation Vice President, Strategic Planning Current
Pharmion Corporation Vice President, Strategic Planning Current
Rivervest Venture Management, LLC Vice President, Strategic Planning Current
Sanofi-Aventis Vice President, Business and Portfolio Analysis Former
Hoechst Marion Roussel Former
Marion Laboratories Former
Marion Merrell Dow Former
Aventis Pharmaceuticals Inc Former
American University Former

Organization Position Status
Pharmion Corporation Vice President, Global Medical & Safety Current
Montagu Newhall Associates, Inc. Vice President Current
Rivervest Venture Management, LLC Vice President, Global Medical and Safety Current
The Mds Foundation Vice President, Global Medical and Safety Current
Quintiles Transnational Corp. Executive Director, Medical and Scientific Services Former
Hoechst Marion Roussel Former
Saint Louis University Masters of Public Health Former

Organization Position Status
Amgen Fremont Senior Vice President, Sales, Marketing Current
Pharmion Corporation Vice President, Sales, Marketing Current
Emd Pharmaceuticals, Inc. Vice President, U.S. Sales and Marketing Former
Wittenberg University Bachelor of Arts degree in Biology Former

Organization Position Status
Pharmion Corporation Vice President, Information Technology Current
Gilead Sciences, Inc. Director, MIS Former

Organization Position Status
Pharmion Corporation Vice President, Information Technology Current

Organization Position Status
Montagu Newhall Associates, Inc. Vice President and General Counsel Current
Rivervest Venture Management, LLC Vice President Current
The Mds Foundation Vice President, General Counsel Current
Pharmion Corporation Vice President and General Counsel Current
Montagu Newhall Associates, Inc. Partner Former
The Mds Foundation Partner Former
Cooley Godward Llp Partner Former
Pharmion Corporation Partner Former
Cooley Godward Llp Associate Former

Organization Position Status
Pharmion Corporation Director, Corp Communications Current

Organization Position Status
Pharmion Corporation Director, Investor Relations Current

Organization Position Status
Pharmion Corporation Director, Conferences Current
Seminars board member Current
The Ohio State University Director Former

Organization Position Status
Pharmion Corporation Current

Organization Position Status
Pharmion Corporation Current
University of Kiel Professor of Medicine Former
Monash University medical degree Former

Organization Position Status
Pharmion Corporation Board of Directors Current

Organization Position Status
Versant Ventures Managing Director Current
Immune Design Corp. Co-Founder and Managing Director of Versant Ventures Current
Brentwood Venture Capital Founder Current
Helicos BioSciences Corporation Current
Cadence Pharmaceuticals, Inc. Chairman Current
Immune Design Corp. Board of Directors Current
Opgen, Inc. Board of Directors Current
Trius Therapeutics, Inc. Board of Directors Current
Phaserx, Inc. Board of Directors Current
Montagu Newhall Associates, Inc. Director Current
Xenogen Corporation Board of Directors Current
The Mds Foundation Board of Directors Current
Fortebio, Inc Board of Directors Current
Salmedix, Inc. Board Member Current
Five Prime Therapeutics, Inc. Board Member Current
Pharmion Corporation Board Member Current
Saegis Pharmaceuticals, Inc Board Member Current
ForteBio Board Member Current
RX3 Pharmaceuticals, Inc Board of Directors Current
Rivervest Venture Management, LLC Director Current
Synosis Board of Directors Current
Versant Ventures Co-Founder Current
The Mds Foundation Member Current
Montagu Newhall Associates, Inc. Member Current
Millipore Corporation CEO Former
Sankyo Co. Ltd. CEO Former
Eli Lilly and Company CEO Former
Glycomed, Inc. CEO Former
Glycomed, Inc. President Former
Eli Lilly and Company President Former
Millipore Corporation President Former
Sankyo Co. Ltd. President Former
Eli Lilly and Company Founder Former
Millipore Corporation Founder Former
Sankyo Co. Ltd. Founder Former
Glycomed, Inc. Founder Former
Brentwood Venture Capital General Partner Former
Brentwood Associates General Partner Former
Brentwood Associates Managing Member Former
Harvard Business School Mba Former
University of California, Davis Master's Degree Former
Harvard University M.B.A. Former
University of California Master's Degree Former
University of California, Irvine Bachelor's Degree In Biological Sciences Former
University of California Bachelors Degree in Biology Former

Organization Position Status
Versant Ventures Managing Director Current
Five Prime Therapeutics, Inc. Board Member Current
Pharmion Corporation Board Member Current
ForteBio Board Member Current
Cadence Pharmaceuticals, Inc. Board Member Current
Glycomed, Inc. CEO Former
Glycomed, Inc. President Former
Glycomed, Inc. Founder Former
Brentwood Venture Capital General Partner Former
PerkinElmer, Inc. Director Former
University of California Master's degree Former
Harvard Business School MBA Former
University of California Bachelor's degree Former

Organization Position Status
Buttonwood Capital Partners Limited Director Current
Sbs Broadcasting Sa Director Current
Rivervest Venture Management, LLC Director Current
Pharmion Corporation Director Current
Healthcare 2007 Board of Directors Current
Trover Solutions, Inc. Director Current
The Mds Foundation Board of Directors Current
American School Board of Trustees Current
Montagu Newhall Associates, Inc. Director Current
The Mds Foundation Member Current
Montagu Newhall Associates, Inc. Member Current
Pharmion Corporation Member Current
McKinsey & Company, Inc. Former
Royal National Theatre Former
Warburg Pincus, LLC Former
Stanford University Board of Directors Former
Yale University MBA Former
Yale School of Management MBA Former

Organization Position Status
Prestwick Pharmaceuticals, Inc Chairman, Pharmaceutical Product Development, Chairman and CEO, Capnia Current
CAPNIA, Inc. Chairman & CEO Current
Park Avenue Equity Partners Partner Current
ICOS Corporation Lead Director Current
University of Rhode Island Adjunct Professor Current
Duke University Trustee Current
University of Maryland Advisor Current
Galileo Pharmaceuticals, Inc. Chairman of the Board of Directors Current
Duke University Health System Board of Directors Current
Taris Biomedical, Inc. Board of Directors Current
Multiple Myeloma Board of Directors Current
Maxygen, Inc. Board of Directors Current
Pathway Diagnostics Corporation Board of Directors Current
Rare Diseases Clinical Research Network Board of Directors Current
Pharmaceutical Product Development, Inc. Director Current
Pharmion Corporation Board of Directors Current
Boston Scientific Corporation Board of Directors Current
Celgene Corporation Board of Directors Current
Lead Discovery Board of Directors Current
Caliper Life Sciences, Inc. Vice-Chairman Current
The Reader's Digest Association, Inc. Director Current
Alza Technologies Corp CEO Former
Ardea Biosciences, Inc.De Chief Executive Officer Former
Reliant Pharmaceuticals, Inc. Chief Executive Officer Former
Reliant Pharmaceuticals, Inc. Chief Executive Former
Bay City Capital LLC Vice President Former
Lee Enterprises, Inc. Publisher Former
ALZA Corporation Executive Officer Former
Squibb Corporation Former
ALZA Corporation Chairman Former
Ardea Biosciences, Inc.De Chairman Former
Duke University Health System Chairman of The Board Former
Alza Technologies Corp Chairman Former
The American Foundation Chairman Former
Reliant Pharmaceuticals, Inc. Chairman of the Board Former
Alexza Pharmaceuticals, Inc. Board of Directors Former
Guidant Corporation Board of Directors Former
University of Rhode Island Master's and Doctoral Degrees In Physical Sciences Former
Rutgers University B.S. In Pharmacy Former
Princeton University Ab Degree Former

Organization Position Status
Pharmion Corporation Board of Directors Current

M. James Barrett, Ph.D. has served as a general partner of NEA Partners 10 Limited Partnership, the general partner of New Enterprise Associates 10 Limited Partnership, a venture capital fund, since August 2001. From January 1997 to August 2001, he served as Chairman and Chief Executive Officer of Sensors for Medicine and Science, Inc., a medical device company, which he founded in 1997. He continues to serve as the Chairman of its Board of Directors. Dr. Barrett also serves on the Boards of Directors of two publicly-held biopharmaceutical companies: Taragacept, Inc. and YM Biosciences, Inc., and the Boards of several privatelyheld biopharmaceutical companies. Dr. Barrett received a B.S. in Chemistry from Boston College, a Ph.D. in Biochemistry from the University of Tennessee and a M.B.A. from the University of Santa Clara.

Organization Position Status
Sensors for Medicine and Science, Inc. Chairman and Founder Current
Iomai Corporation General Partner Current
Iomai Corporation Chairman Current
Nucleonics Inc Chairman Current
Glycomimetics, Inc. Chairman Current
Rivervest Venture Management, LLC Director Current
Peptimmune, Inc. Board of Directors Current
Inhibitex, Inc. Board of Directors Current
Pharmion Corporation Board of Directors Current
Sensors, Inc. Board of Directors Current
Targacept, Inc. Board of Directors Current
Targacept, Inc. Board of Directors Current
Cogenesys Board of Directors Current
Ruxton Board of Directors Current
The Science Company Chief Executive Officer Former
Genetic Therapy, Inc. CEO Former
Sensors, Inc. Founder Former
Genetic Therapy, Inc. Founder Former
SmithKline Beecham Corporation Former
The Science Company Chairman Former
Genetic Therapy, Inc. Chairman Former
Nucleonics Inc Board of Directors Former
Glycomimetics, Inc. Board of Directors Former
The University of Tennessee PhD In Biochemistry Former
University of Santa Clara MBA Former
Boston College BS In Chemistry Former

Mr. Blair has been a General Partner of Domain Associates since its founding in 1985. He has over thirty years experience with venture and emerging growth companies. In the course of this experience, he has been involved with the creation and successful development as a board member of over forty life science ventures including Amgen, Amylin Pharmaceuticals, Applied Biosystems, Aurora Biosciences, Dura Pharmaceuticals, Sicor, and Molecular Dynamics. A former Managing Director of Rothschild Inc., Mr. Blair was directly involved at a senior level with Rothschild/New Court venture capital activities from 1978 to 1985. From 1969 to 1978, he was associated with F.S. Smithers and Company, and White Weld and Company, two investment banking firms actively involved with new ventures and emerging growth companies. From 1961 to 1969, Mr. Blair was an engineering manager with RCA during which time he received a David Sarnoff Fellowship. Mr. Blair is presently an Advisor to the Department of Molecular Biology at Princeton University, an Advisor to the Department of BioEngineering at the University of Pennsylvania, and he also serves on the Board of Directors of CapCure.

Organization Position Status
Genvault Corporation Partner at Domain Associates Current
Domain Inc. Partner Current
Domain Associates LLC Partner Current
Princeton University Advisory Boards Current
University of Pennsylvania Advisory Boards Current
Reebie Current
Genvault Corporation Board of Directors Current
Counselors Inc. Board of Directors Current
Zogenix, Inc. Board of Directors Current
Meritage Pharma, Inc. Board of Directors Current
Cell Biosciences, Inc. Board Member Current
Montagu Newhall Associates, Inc. Advisory Board Member Current
Five Prime Therapeutics, Inc. Board of Directors Current
Cell Biosciences, Inc Board of Directors Current
Pharmion Corporation Board of Directors Current
NuVasive, Inc. Board of Directors Current
Cadence Pharmaceuticals, Inc. Board of Directors Current
Ferrer, Freeman & Company, Inc. Board of Directors Current
Neuropace, Inc. Board Member Current
Coda Therapeutics, Inc. Board of Directors Current
Novacea, Inc. Board of Directors Current
The Prostate Cancer Foundation Board of Directors Current
Helixis, Inc. Board of Directors Current
Domain Associates LLC Managing Member Current
Rothschild Inc. Managing Director Former
RCA Corporation engineering manager Former
University of Pennsylvania Advisor Former
White, Weld and Company associated Former
Federal Highway Administration Former
General Motors Corporation Former
Consolidated Rail Corporation Former
Amgen Inc. Board Member Former
Volcano Corporation Board of Directors Former
Dura Pharmaceuticals, Inc. Board Member Former
Aurora Biosciences Corporation Board Member Former
Applied Biosystems Group Board Member Former
Sicor, Inc. Board Member Former
Amylin Pharmaceuticals, Inc. Board Member Former
Princeton University Ph.D. Former
University of Pennsylvania Ph.D Former
University of Pennsylvania M.S.E Former
The Pennsylvania State University BSc in Business Logistics Former
Princeton University B.S.E. Former

Jim Loughlin was named to the Celgene Board of Directors in January 2007, and serves as a member of the Audit Committee. Mr. Loughlin, an experienced corporate director served as the National Director of the Pharmaceuticals Practice at KPMG, including a five-year term as member of the Board of Directors of KPMG LLP. Additionally, Mr. Loughlin served as Chairman of the Pension and Investment Committee of the KPMG Board from 1995 through 2001. He also served as Partner in charge of Human Resources, Chairman of the Personnel and Professional Development Committee, Secretary and Trustee of the Peat Marwick Foundation and a member of the Pension, Operating and Strategic Planning Committees.

Organization Position Status
Celgene Corporation Board of Directors Current
Multiple Myeloma Board of Directors Current
Pharmion Corporation Board of Directors Current
Lead Discovery Board of Directors Current
Rare Diseases Clinical Research Network Board of Directors Current
Celgene Corporation Member of the Audit Committee Current

Organization Position Status
Burnham Institute for Medical Research President and CEO, Professor and Donald Bren Presidential Chair Current
Aperio Technologies, Inc. President & CEO, Burnham Institute for Medical Research Current
Predictive Biosciences, Inc. President & Chief Executive Officer, Burnham Institute for Medical Research Current
Sanford Consortium President and Chief Executive Officer of the Burnham Institute for Medical Research Current
Garden of Healing President and Chief Executive Officer of the Burnham Institute for Medical Research Current
Idun Pharmaceuticals, Inc. Co-Founder Current
University of California, San Diego School of Medicine Adjunct Prof Current
University of Florida Adjunct Professor Current
University of California, San Diego Adjunct Professor Current
Rivervest Venture Management, LLC Director Current
Genetrove™ Board of Directors Current
Montagu Newhall Associates, Inc. Director Current
Sanford Consortium Board of Directors Current
OSI Pharmaceuticals, Inc. Board of Directors Current
Simonpure Productions, LLC Board of Directors Current
The Mds Foundation Board of Directors Current
Predictive Biosciences, Inc. Board of Directors Current
Guava Technologies, Inc. Board of Directors Current
Pharmion Corporation Director Current
Idun Pharmaceuticals, Inc. Board of Directors Current
Isis Pharmaceuticals, Inc. Board of Directors Current
Biocom, Inc. Board of Directors Current
Montagu Newhall Associates, Inc. Member Current
Pharmion Corporation Member Current
The Mds Foundation Member Current
Isis Pharmaceuticals, Inc. President and Chief Executive Officer, the Burnham Institute Former
The Burnham Institute CEO Current
University of Pennsylvania Assistant Director Former
Laboratory Medicine Assistant Director Former
University of Pennsylvania School of Medicine Assistant Director Former
Wistar Institute of Anatomy & Biology Inc. Postdoctoral Fellow Former
University of Pennsylvania School of Medicine Assistant Professor Former
The Burnham Institute Board of Directors Former
University of Pennsylvania School of Medicine Doctorate Degrees Former
San Diego State University Former
University of Virginia Former

Array

Organization Position Status
Renovis, Inc. Founder of Pharmion Current
Pharmion Corporation Board of Directors Current
Chroma Therapeutics Ltd Board of Directors Current
PRA International Inc. Board of Directors Current
The Perrigo Company Board of Directors Current
ZymoGenetics, Inc. Board of Directors Current
Pharmion Corporation Executive Vice President and Chief Operating Officer Former
AVAX Technologies, Inc. Senior Vice President, Business Development Former
Renovis, Inc. Consultant Former
Marion Laboratories Consultant Former
Hoechst Marion Roussel Former
Marion Merrell Dow Former
University of Missouri Ph.D. Former
Rockhurst University M.B.A. Former
Benedictine College B.S. Degree Former
University of Missouri B.S. In Biology Former
Rockhurst University B.S. In Biology Former
Pharmion Corporation Member Former

Organization Position Status
Sensors for Medicine and Science, Inc. Chairman Former
Iomai Corporation Board Member Current
Inhibitex, Inc. Board Member Current
Pharmion Corporation Board Member Current
Targacept, Inc. Board of Directors Current
Sensors for Medicine and Science, Inc. Chief Executive Officer Former
Genetic Therapy, Inc. Chief Executive Officer Former
SmithKline Beecham Corporation President Former
New Enterprise Associates General Partner Former
Peptimmune, Inc. Former
Genetic Therapy, Inc. Director Former
The University of Tennessee Doctorate in Biochemistry Former
University of Santa Clara Master's Degree in Business Administration Former

Organization Position Status
The Student Loan Corporation Managing Partner Current
The Student Loan Corporation Chair, Audit Committee Current
Celgene Corporation Board of Directors Current
Crystal River Capital, Inc. Director Current
The Student Loan Corporation Board of Directors Current
Excelsior Funds, Inc Director Current
Jackson Hewitt Tax Service Inc. Board of Directors Current
Pharmion Corporation Board of Directors Current
Parsons Brinckerhoff Inc. Board of Directors Current
Lead Discovery Board of Directors Current
Pharmion Corporation Committee Member Current
Celgene Corporation Member of the Audit Committee Current
Multiple Myeloma Committee Member Current
Rare Diseases Clinical Research Network Committee Member Current
Cresap Incorporated Former

Organization Position Status
Pharmion Corporation Board of Directors Current

Organization Position Status
Pharmion Corporation Board of Directors Current

Organization Position Status
Bay City Capital LLC principal Current
Sunesis Pharmaceuticals, Inc. Board of Directors Current
Pharmion Corporation Investor Current
Roth Capital Partners LLC Vice President Former
Medarex, Inc. Sell, side analyst Former
NeoRx Corporation Sell, side analyst Former
IDEC Pharmaceuticals Sell, side analyst Former
Pharmion Corporation board observer Former
University of California, San Diego BA in Economics Former

Organization Position Status
DURECT Corporation Director, Chairman of the Nominating and Governance Committee Current
Allos Therapeutics, Inc. Pharmaceutical Industry Consultant Current
DURECT Corporation Director Current
Cholestech Corporation Director Current
Lead Discovery Board of Directors Current
AVI BioPharma, Inc. Director Current
Bone Care International, Inc. Director Current
Celgene Corporation Board of Directors Current
Inex Pharmaceuticals Corporation Director Current
Orthologic Corporation Director Current
Allos Therapeutics, Inc. Director Current
Multiple Myeloma Committee Member Current
Pharmion Corporation Committee Member Current
Rare Diseases Clinical Research Network Committee Member Current
Genetic Therapy, Inc. President Former
Genetic Therapy, Inc. Chief Operating Officer Former
Ortho Pharmaceutical Corporation Vice President, Sales and Marketing Former
Johnson & Johnson Vice President of Sales and Marketing Former

Organization Position Status
Montagu Newhall Associates, Inc. Member Current
Pharmion Corporation Member Current
The Mds Foundation Member Current
Montagu Newhall Associates, Inc. Board of Directors Current
Rivervest Venture Management, LLC Director Current
Pharmion Corporation Director Current
The Mds Foundation Board of Directors Current

Executive News

  • Lawsuit Alleges Celgene Took Idea For Drug's Usage

    Morningstar.com - 8/25/09 - View Story

  • UPDATE: Lawsuit Alleges Celgene Took Idea For Drug's Usage

    Morningstar.com - 8/25/09 - View Story

  • Team behind Pharmion launching Clovis, a cancer-focused biotech

    The Denver Business Journal - 5/21/09 - View Story

  • Clovis Oncology Gets $145 Mln Start-Up Cash - Update

    RTTNews.com - 5/21/09 - View Story

  • Clovis Oncology Raises $145 Million in Start-Up Financing

    Reuters - 5/21/09 - View Story

  • Clovis Oncology Raises $145 Million in Start-Up Financing

    Street Insider - 5/21/09 - View Story

  • Clovis Oncology Raises $145 Million in Start-Up Financing

    San Francisco Business Times - 5/21/09 - View Story

advertisement
Click Here
     PHRM $12.00 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 91
Shares Outstanding -
Market Cap -
Year High 72.32
Year Low 1.25
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here